SOURCE: MIT Holding, Inc.


March 11, 2014 07:30 ET

AMGP Georgia Managed Care Company, Inc. Expands Existing MIT Holding, Inc. (MITD) Contract

SAVANNAH, GA--(Marketwired - Mar 11, 2014) - MIT Holding, Inc. (OTCQB: MITD) announces that AMGP GEORGIA MANAGED CARE COMPANY, INC., D.B.A. Amerigroup Community Care, revised a "Participating Provider Agreement" to include ambulatory, infusion and perinatal services to the existing "Durable Medical Equipment Contract" (DME). Therefore, the contract will now pay for all services offered by MITD, for a demographically larger range of patients. 

AMGP Georgia Managed Care Company, Inc. is a Georgia Care Maintenance Organization (CMO). They serve members in the Georgia Families Programs, such as, Medicaid and PeachCare for Kids. AMGP is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. 

Walter Drakeford, MIT Holding, Inc.'s CEO stated, "We've diversified MIT Holding from the beginning as a segmented divisional Company. This structure allows maximum focus for the client's benefit from one division, while maintaining a nimble enough philosophy to add 'overnight' services from our other divisions. In our case, the client can be the patient, the medical facility, or the insurance carrier. AMGP' s decision to expand the existing DME contract to include these additional divisions highlights the success of MITD's market strategy. "

MITD is designed for organic growth, as well as, aggressive acquisition programs. This contract expansion adds an additional layer of service benefits, which significantly increasing MITD's Medicaid billing. Management continues to look for growth strategies which will enhance the Company's revenue streams and shareholder value.

About MIT Holding, Inc.

Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Dominican Republic, Haiti, Costa Rica, the Bahamas, Argentina, and Brazil. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.

For more information, contact Mr. William Nalley, Orsay Groupe,, phone 305-790-2688 and/or visit

Forward-Looking Statements:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.

Contact Information